Developer docs
API playgroundTry for free, no card

Search company profiles

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen

Full company profile

uuid004klh8

Namestring
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen
Legal namestring
Helmholtz-Institut für Biomedizinische Technik der RWTH Aachen University
Company typeenum
Private
Founded yearint
1971
Descriptiontext

The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster (Arbeitsgemeinschaft) operating under RWTH Aachen University, a public law corporation (Körperschaft des öffentlichen Rechts) in North Rhine-Westphalia, Germany. The legal name is "Helmholtz-Institut für Biomedizinische Technik der RWTH Aachen University," founded in 1971 under sponsorship of Forschungsgesellschaft für Biomedizinische Technik e.V. Aachen following a Volkswagenwerk Foundation call for tenders. HIA was fundamentally restructured in 2001 when it was formally integrated into RWTH Aachen University through a cooperation agreement across four participating faculties. The institute unites seven institutes from four faculties (Medicine, Mechanical Engineering, Electrical Engineering and Information Technology, Mathematics and Natural Sciences) and is co-located with the University Hospital Aachen for clinical translation. HIA marked its 50th anniversary with a one-day symposium on 28 June 2024.

HIA's research portfolio is organized around seven chairs and research areas including Applied Medical Engineering (AME, encompassing biohybrid medical textiles, cardiovascular engineering, computational mechanics, and neuromechanics/assistive robotics); Medical Information Technology (MedIT, focused on closed-loop therapy devices, biomechatronics, bioimpedance spectroscopy/EIT, wearables, intelligent textiles, and contactless measurement with signal processing/AI); Medical Engineering (mediTEC, covering biomechanical modeling/simulation, image-guided surgery, mechatronics, robotics, ultrasound/shockwaves); Biomaterials (glycobiotechnology, polymeric building blocks for soft 3D biomaterials); Experimental Molecular Imaging (ExMI, nanoparticles for cancer radio-immunotherapy and theranostics); Stem Cell Biology; and the Biointerface Laboratory (cell and molecular biology at interfaces). Notable research outputs include sensor-free contactless monitoring systems for premature infants, biohybrid implants for cardiovascular and respiratory systems, AI-based signal processing for wearable medical devices, and image-/model-guided surgical technology.

HIA does not operate a commercial business model. As a public university research institute, its activities are funded through public research grants, third-party funding (Drittmittel), and institutional support from RWTH Aachen University, with revenue not publicly disclosed. HIA does not produce commercial products, charge customers, or offer APIs or SDKs. It serves three primary constituencies: the University Hospital Aachen as clinical translation partner, the medical technology industry for collaborative research and technology transfer (including an annual excursion partnership with B. Braun Melsungen), and students/researchers participating in cross-faculty biomedical engineering education. Distribution occurs through academic publications, the biennial Helmholtz Symposium Aachen, the regular BMT-Kolloquium seminar series, annual research reports, GDPR/BITV-compliant web dissemination, and direct technology-transfer collaborations with industry and international partners such as KTH Royal Institute of Technology Stockholm.

Short descriptiontext

HIA is a cooperative research cluster under RWTH Aachen University uniting seven biomedical engineering institutes across four faculties. It conducts interdisciplinary R&D in medical devices, biomaterials, molecular imaging, and stem cell biology, partnering with University Hospital Aachen for clinical translation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAachen, Germany
HQ citystring
Aachen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical engineering research, medical information technology, biomaterials and glycobiotechnology, molecular imaging research, stem cell biology
NAICS code4 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Academic Biomedical Engineering Research
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster comprising seven institutes from four faculties of RWTH Aachen University and the University Hospital Aachen. It conducts interdisciplinary basic and application-oriented research in biomedical engineering — spanning medical technology, information technology, biomaterials, molecular imaging, and stem cell biology — aimed at improving patient diagnosis, therapy, and rehabilitation. It also coordinates cross-faculty teaching and runs academic events such as the Helmholtz Symposium Aachen and the BME-Colloquium.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Development of sensor-free monitoring systems for premature infants
+2 more records
Product overview1 text field

The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster comprising seven chairs and research areas from four faculties of RWTH Aachen University and University Hospital Aachen. The institute focuses on interdisciplinary biomedical engineering research and education rather than commercial product development. Its portfolio includes research chairs in Medical Information Technology (MedIT) focused on wearable medical devices and closed-loop therapy systems; Medical Engineering (mediTEC) focused on biomechanical simulation and surgical robotics; Applied Medical Engineering (AME) focused on biohybrid medical textiles and cardiovascular engineering; Biomaterials focused on glycobiotechnology; Experimental Molecular Imaging (ExMI) focused on nanomedicines for cancer therapy; plus Stem Cell Biology and Biointerface Laboratory at the University Hospital. The institute also organizes the biennial Helmholtz Symposium Aachen and regular BMT-Kolloquium events for academic exchange.

Product and service1 record
1Chair for Medical Information Technology (MedIT)
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2001-01-01
Description

Integration into RWTH Aachen University in 2001 with the Faculty of Medicine taking over the institute; establishment of the Helmholtz-Institute for Biomedical Engineering Work Community through cooperation agreement between Medical Faculty, Faculty of Electrical Engineering and Information Technology, Faculty of Mechanical Engineering, and Faculty of Mathematics, Computer Science and Natural Sciences.

2University Hospital Aachen (UK Aachen)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2001-01-01
Description

Close partnership with University Hospital Aachen for clinical translation of biomedical engineering research; hosts several HIA institutes including Institute for Applied Medical Engineering, Institute for Experimental Molecular Imaging, Institute for Stem Cell Biology, and Institute for Cell and Molecular Biology at Interfaces.

hia.rwth-aachen.de
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research collaboration through Digital Futures Excellence Cluster; Prof. Steffen Leonhardt conducting three-month research stay at KTH Stockholm, hosted by Prof. Seraina Dual in Technology and Health Division near Karolinska Institut.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Annual Pentecost excursion to B. Braun facilities providing insights into medical device manufacturing including dialysis equipment and sterilization processes; exchange between science and industry through lectures and plant tours.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cooperation partner hosting the Chair for Medical Information Technology (MedIT) and contributing to interdisciplinary biomedical engineering research within HIA.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cooperation partner hosting the Chair for Medical Engineering (mediTEC) and contributing to interdisciplinary biomedical engineering research within HIA.

7Faculty of Mathematics, Computer Science and Natural Sciences (RWTH)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cooperation partner hosting the Teaching and Research Area for Biomaterials and contributing to interdisciplinary biomedical engineering research within HIA.

hia.rwth-aachen.de
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Long-standing US biomedical engineering department known for biomaterials, medical devices and clinical translation — peer in mission and translational posture to HIA.

TypeRegional player
Description

Sweden's medical university with strong translational medical technology work; HIA has an active research collaboration with KTH Stockholm hosted near Karolinska, making it a relevant international peer.

TypeBroad incumbent
Description

Large European university department combining biomedical engineering, materials, imaging and clinical translation — a natural academic peer to HIA's cross-faculty biomedical engineering model.

TypeRegional player
Description

Aachen-based materials research institute with biomedical applications; geographically co-located peer working on biomaterials adjacent to HIA's glycobiotechnology work.

TypeBroad incumbent
Description

Top US biomedical engineering department with strong medical device, imaging and tissue engineering programs — comparable in research breadth and clinical integration to HIA.

TypeBroad incumbent
Description

Leading European biomedical engineering department with strong biomaterials, bioimaging, and medical device work — directly comparable to HIA in research scope and academic structure.

7TU Munich – Institute of Medical Engineering (IMETUM)
TypeDirect peer
Description

German technical university's interdisciplinary medical engineering institute combining mechanics, electronics and clinical applications — the closest domestic structural peer to HIA.

TypeBroad incumbent
Description

German applied-research institute focused on medical image computing, AI for diagnostics, and clinically translatable software — directly comparable to HIA's experimental molecular imaging and medical information technology workstreams.

TypeBroad incumbent
Description

Another Helmholtz-associated biomedical engineering/molecular imaging research hub in Germany; comparable as a German public research consortium translating engineering into clinical and biological applications.

TypeBroad incumbent
Description

Cross-faculty medical engineering institute bridging engineering and medicine at MIT; analogous mission and cross-disciplinary structure to HIA's Arbeitsgemeinschaft model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen

Academic Biomedical Engineering Researchhia.rwth-aachen.de

HIA is a cooperative research cluster under RWTH Aachen University uniting seven biomedical engineering institutes across four faculties. It conducts interdisciplinary R&D in medical devices, biomaterials, molecular imaging, and stem cell biology, partnering with University Hospital Aachen for clinical translation.

What Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen does

The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster (Arbeitsgemeinschaft) operating under RWTH Aachen University, a public law corporation (Körperschaft des öffentlichen Rechts) in North Rhine-Westphalia, Germany. The legal name is "Helmholtz-Institut für Biomedizinische Technik der RWTH Aachen University," founded in 1971 under sponsorship of Forschungsgesellschaft für Biomedizinische Technik e.V. Aachen following a Volkswagenwerk Foundation call for tenders. HIA was fundamentally restructured in 2001 when it was formally integrated into RWTH Aachen University through a cooperation agreement across four participating faculties. The institute unites seven institutes from four faculties (Medicine, Mechanical Engineering, Electrical Engineering and Information Technology, Mathematics and Natural Sciences) and is co-located with the University Hospital Aachen for clinical translation. HIA marked its 50th anniversary with a one-day symposium on 28 June 2024.

HIA's research portfolio is organized around seven chairs and research areas including Applied Medical Engineering (AME, encompassing biohybrid medical textiles, cardiovascular engineering, computational mechanics, and neuromechanics/assistive robotics); Medical Information Technology (MedIT, focused on closed-loop therapy devices, biomechatronics, bioimpedance spectroscopy/EIT, wearables, intelligent textiles, and contactless measurement with signal processing/AI); Medical Engineering (mediTEC, covering biomechanical modeling/simulation, image-guided surgery, mechatronics, robotics, ultrasound/shockwaves); Biomaterials (glycobiotechnology, polymeric building blocks for soft 3D biomaterials); Experimental Molecular Imaging (ExMI, nanoparticles for cancer radio-immunotherapy and theranostics); Stem Cell Biology; and the Biointerface Laboratory (cell and molecular biology at interfaces). Notable research outputs include sensor-free contactless monitoring systems for premature infants, biohybrid implants for cardiovascular and respiratory systems, AI-based signal processing for wearable medical devices, and image-/model-guided surgical technology.

HIA does not operate a commercial business model. As a public university research institute, its activities are funded through public research grants, third-party funding (Drittmittel), and institutional support from RWTH Aachen University, with revenue not publicly disclosed. HIA does not produce commercial products, charge customers, or offer APIs or SDKs. It serves three primary constituencies: the University Hospital Aachen as clinical translation partner, the medical technology industry for collaborative research and technology transfer (including an annual excursion partnership with B. Braun Melsungen), and students/researchers participating in cross-faculty biomedical engineering education. Distribution occurs through academic publications, the biennial Helmholtz Symposium Aachen, the regular BMT-Kolloquium seminar series, annual research reports, GDPR/BITV-compliant web dissemination, and direct technology-transfer collaborations with industry and international partners such as KTH Royal Institute of Technology Stockholm.

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen firmographics

Firmographics
Name
Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen
Legal name
Helmholtz-Institut für Biomedizinische Technik der RWTH Aachen University
Website
https://hia.rwth-aachen.de
Company type
Private
Founded year
1971
Operating status
Operating
Headcount range
11–50 employees
Short description
HIA is a cooperative research cluster under RWTH Aachen University uniting seven biomedical engineering institutes across four faculties. It conducts interdisciplinary R&D in medical devices, biomaterials, molecular imaging, and stem cell biology, partnering with University Hospital Aachen for clinical translation.
Ownership category
akta.pro rank

Where Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen is headquartered

Location

Headquarters

HQ city
Aachen
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Distribution channels1 record

Marketing channels6 records

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen product offering

Product offering

Core offering

The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster comprising seven institutes from four faculties of RWTH Aachen University and the University Hospital Aachen. It conducts interdisciplinary basic and application-oriented research in biomedical engineering — spanning medical technology, information technology, biomaterials, molecular imaging, and stem cell biology — aimed at improving patient diagnosis, therapy, and rehabilitation. It also coordinates cross-faculty teaching and runs academic events such as the Helmholtz Symposium Aachen and the BME-Colloquium.

Product overview

The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster comprising seven chairs and research areas from four faculties of RWTH Aachen University and University Hospital Aachen. The institute focuses on interdisciplinary biomedical engineering research and education rather than commercial product development. Its portfolio includes research chairs in Medical Information Technology (MedIT) focused on wearable medical devices and closed-loop therapy systems; Medical Engineering (mediTEC) focused on biomechanical simulation and surgical robotics; Applied Medical Engineering (AME) focused on biohybrid medical textiles and cardiovascular engineering; Biomaterials focused on glycobiotechnology; Experimental Molecular Imaging (ExMI) focused on nanomedicines for cancer therapy; plus Stem Cell Biology and Biointerface Laboratory at the University Hospital. The institute also organizes the biennial Helmholtz Symposium Aachen and regular BMT-Kolloquium events for academic exchange.

Differentiator

Problem solved

Functional benefit

Products and services

  • Chair for Medical Information Technology (MedIT)

Quantifiable outcome

  • Development of sensor-free monitoring systems for premature infants
  • +2 more outcomes

Companies that use Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen

Customer profile

Segments3 records

Ideal customer profiles3 records

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • RWTH Aachen University (Faculty of Medicine)coreStrategic or Co-development Partner · 1 January 2001Integration into RWTH Aachen University in 2001 with the Faculty of Medicine taking over the institute; establishment of the Helmholtz-Institute for Biomedical Engineering Work Community through cooperation agreement between Medical Faculty, Faculty of Electrical Engineering and Information Technology, Faculty of Mechanical Engineering, and Faculty of Mathematics, Computer Science and Natural Sciences.
  • University Hospital Aachen (UK Aachen)coreStrategic or Co-development Partner · 1 January 2001Close partnership with University Hospital Aachen for clinical translation of biomedical engineering research; hosts several HIA institutes including Institute for Applied Medical Engineering, Institute for Experimental Molecular Imaging, Institute for Stem Cell Biology, and Institute for Cell and Molecular Biology at Interfaces.
  • KTH Royal Institute of Technology StockholmminorStrategic or Co-development PartnerResearch collaboration through Digital Futures Excellence Cluster; Prof. Steffen Leonhardt conducting three-month research stay at KTH Stockholm, hosted by Prof. Seraina Dual in Technology and Health Division near Karolinska Institut.
  • B. Braun MelsungenminorStrategic or Co-development PartnerAnnual Pentecost excursion to B. Braun facilities providing insights into medical device manufacturing including dialysis equipment and sterilization processes; exchange between science and industry through lectures and plant tours.
  • Faculty of Electrical Engineering and Information Technology (RWTH)coreStrategic or Co-development PartnerCooperation partner hosting the Chair for Medical Information Technology (MedIT) and contributing to interdisciplinary biomedical engineering research within HIA.
  • Faculty of Mechanical Engineering (RWTH)coreStrategic or Co-development PartnerCooperation partner hosting the Chair for Medical Engineering (mediTEC) and contributing to interdisciplinary biomedical engineering research within HIA.
  • Faculty of Mathematics, Computer Science and Natural Sciences (RWTH)coreStrategic or Co-development PartnerCooperation partner hosting the Teaching and Research Area for Biomaterials and contributing to interdisciplinary biomedical engineering research within HIA.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen competitors and assessment

Company assessment

Broad incumbents

Regional players

Direct peers

  • TU Munich – Institute of Medical Engineering (IMETUM): German technical university's interdisciplinary medical engineering institute combining mechanics, electronics and clinical applications — the closest domestic structural peer to HIA.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen social profiles

Digital presence

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen compliance and trust

Trust signal

Compliance4 records

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen leadership team

Management profile

Number of profiles

Profiles8 records

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen

What does Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen do?

The Helmholtz-Institute for Biomedical Engineering (HIA) is a cooperative research cluster comprising seven institutes from four faculties of RWTH Aachen University and the University Hospital Aachen. It conducts interdisciplinary basic and application-oriented research in biomedical engineering — spanning medical technology, information technology, biomaterials, molecular imaging, and stem cell biology — aimed at improving patient diagnosis, therapy, and rehabilitation. It also coordinates cross-faculty teaching and runs academic events such as the Helmholtz Symposium Aachen and the BME-Colloquium.

Is Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen a public or private company?

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen is a private company. It is classified as state government owned and is currently operating.

When was Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen founded?

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen was founded in 1971. It employs 11 to 50 people.

Where is Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen based?

Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen is headquartered in Aachen, Germany, in the Europe region.

Who are Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen's main competitors?

Broad incumbents on record are Case Western Reserve University Department of Biomedical Engineering, ETH Zurich – Department of Health Sciences and Technology, Johns Hopkins Department of Biomedical Engineering, Imperial College London – Department of Bioengineering, Fraunhofer Institute for Digital Medicine MEVIS, Helmholtz Zentrum München – Institute for Biomedical Engineering and MIT Institute for Medical Engineering and Science (IMES). Regional players are Karolinska Institutet – Department of Medical Engineering and Leibniz Institute for Interactive Materials (DWI). TU Munich – Institute of Medical Engineering (IMETUM) is listed as a direct peer.

Does Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen have an API?

No public API is recorded for Helmholtz-Institut - RWTH Aachen und Universitätsklinikum Aachen.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales